Related content

Estrogen receptor α CA dinucleotide repeat polymorphism is associated with rate of bone loss in perimenopausal women and bone mineral density and risk of osteoporotic fractures in postmenopausal women

By Lai B.   Cheung C.   Luk K.   Kung A.  

Osteoporosis International, Vol. 19, Iss. 4, 2008-04 ,pp. : 571-579

Springer Publishing Company

Access to resources Recommend Favorite

Effects of estrogen therapy on bone marrow adipocytes in postmenopausal osteoporotic women

By Syed F.   Oursler M.   Hefferanm T.   Peterson J.   Riggs B.   Khosla S.  

Osteoporosis International, Vol. 19, Iss. 9, 2008-09 ,pp. : 1323-1330

Springer Publishing Company

Access to resources Recommend Favorite

Relationship Between Baseline Insulin‐Like Growth Factor‐I (IGF‐I) and Femoral Bone Density in Women Aged Over 70 Years: Potential Implications for the Prevention of Age‐Related Bone Loss

By  

JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol. 44, Iss. 11, 1996-11 ,pp. : 1301-1306

John Wiley & Sons Inc

Access to resources Recommend Favorite

Calcitriol does not prevent bone loss in patients with asthma receiving corticosteroid therapy: a double-blind placebo-controlled trial

By McDonald C.   Zebaze R.   Seeman E.  

Osteoporosis International, Vol. 17, Iss. 10, 2006-10 ,pp. : 1546-1551

Springer Publishing Company

Access to resources Recommend Favorite

Loss of vertebral bone and mechanical strength in estrogen-deficient rats is prevented by long-term administration of zoledronic acid

By Glatt Markus   Pataki Alexander   Evans G.   Hornby Simon   Green Jonathan  

Osteoporosis International, Vol. 15, Iss. 9, 2004-09 ,pp. : 707-715

Springer Publishing Company

Access to resources Recommend Favorite